Table 1 Characteristics and clinical course of published cases of liposarcoma of the spermatic cord
No. | age (y) | Duration | Location | Size (cm) | Treatment | Pathology | Follow –up | Outcome |
|---|---|---|---|---|---|---|---|---|
12 | 53 | NA | L.s | 6 × 7 | RO | WDL | 3 yr | Recurrence |
22 | 70 | 6 mo | R.s | 13 × 7 × 3.5 | RO | WDL | 6 yr | Recurrence |
32 | 34 | NA | L.s | 1.5 × 2.5 | RO | WDL | 4 yr | NRD |
42 | 56 | 10 yr | L.s | 8.5 × 7.5 × 4.5 | RO+rad | PDL, WDL | 18 mo | NRD |
52 | 53 | NA | L.s | NA | RO | DL | 18 mo | NRD |
62 | 71 | 2 yr | L.s | NA | RO | WDL | 3 mo | NRD |
75 | 59 | 5 yr | L.s | 50 × 27.5 × 15 (10.9 kg) | RO | WDL | 3 yr | NRD |
86 | 60 | 7 mo | R.s; RP | 14 × 3.8 × 3.5; 24 × 10 × 8 | TR; RO | WDL (St) | 4 yr | NRD |
97 | 71 | 5 mo | L.s | 9.5 × 5.5 | RO | DL | 4 mo | NRD |
108 | 52 | 3 mo | L.s | 0.4 | TR | WDL | 3 yr | NRD |
1110 | 69 | 1 yr | L.s | 16 × 6 × 5 | RO+rad | WDL (St) | NA | NA |
1211 | 53 | 6 mo | R.s | 7.5 × 4.5 × 4 | RO | WDL (St) | NA | NA |
1312 | 76 | 1 wk | L.s | 6 × 5 × 3 | TR | WDML | NA | NA |
1413 | 24 | 6 mo | R.s | 5 | TR | WDML | 1 yr | NRD |
1514 | 79 | 3 mo | L.s | 12 × 6 (730 g) | RO | ML | 1 yr | NRD |
1615 | 60 | 4 yr | R.s | 15 × 20 (760 g) | RO | WDML | NA | NA |
1716 | 44 | 1 yr | L.s | 20 × 15 | RO | WDL (St) | 1 yr | NRD |
1817 | 60 | 6 yr | R.s | 5 × 4 | RO | WDL | 3 yr | NRD |
1918 | 75 | 18 mo | L.s | 20 × 15 | RO | ML | NA | NA |
2018 | 54 | NA | L.s | 20 × 20 | RO | PL | NA | NA |
2119 | 73 | 6 mo | R.s | 15 × 10 × 14 | RO | WDL | 8 yr | NRD |
2219 | 47 | NA | R.s | 3 | RO | WDL | 20 mo | NRD |
2320 | 73 | 1 yr | R.s | 17 × 13 × 4 | RO rad | DL | 2 yr | NRD |
2420 | 68 | 1mo | R.s | 8 × 6 × 6 | RO | WDL (St) | 6 mo | NRD |
2522. | 73 | NA | L.s; RP | 4.1 × 3.5 × 3; 3.3 × 3.3 × 2 | RO; TR | NA | 6 mo | NRD |
2623 | 40 | NA | R.s | 50 × 50 × 35 (42 kg) | TR | WDL (St) | 12 mo | NRD |
2724 | 65 | NA | R.s | 34 × 22 × 17 (5,786 g) | RO | DL | 48 mo | NRD |
2825 | 75 | NA | NA | 14 × 8 × 9 | RO | PL | NA | NA |
2926 | 47 | 6 mo | L.s | 4 × 3 × 3; 4 × 2 × 2 | RO | WDML; A | 30 mo | NRD |
3027 | 73 | 18 mo | L.s | 10 × 8 × 7 | RO | ML | NA | NA |
3129 | 65 | 1 yr | R.s | 14 × 8 × 5 | RO | WDML | 3 mo | NRD |
3230 | 64 | 4 yr | L.s | 26 × 15 × 7 (785 g) | RO | WDL | 3 mo | NRD |
3332 | 57 | 1.5 yr | L.s | 11 × 7.5 × 5 | RO+rad | DL | 10 yr | NRD |
3432 | 60 | NA | R.s | 3 × 1.8 × 1.5 | RO | WDL (St) | 1 yr | Recurrence |
3533 | 57 | 1 yr | L.s | 9 × 6.5 | RO+rad | DL | NA | NA |
3634 | 66 | 3 mo | R.s | 5 × 10 | RO | PDML | 6 mo | Metastases |
3735 | 60 | 1 yr | L.s | 10 × 10 × 5 | RO | WDL (St) | 3 yr | Recurrence |
3836 | 48 | 2 yr | R.s | NA | RO | WDL | 3 yr | NRD |
Our case | 53 | 2 yr | L.s | 6 × 5 × 3 | RO | WDML | 18 mo | NRD |